12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Tuesday's pre-market session, several healthcare stocks showed significant movement. Dynatronics led the gainers with an 84.9% increase, while Inovio Pharmaceuticals experienced the largest drop among the losers, falling 24.3%. Other notable movers included BioRestorative Therapies, Akanda, and Cullinan Oncology with substantial gains, and Calidi Biotherapeutics, Dermata Therapeutics, and Addex Therapeutics among the biggest losers.
April 16, 2024 | 12:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Akanda's shares increased by 23.0% to $0.14, with a market cap of $1.6 million.
Akanda's notable pre-market gain suggests investor confidence or positive developments within the company, pointing to a positive short-term impact on its stock price.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
BioRestorative Therapies' shares rose 23.48% to $1.63, with a market cap of $11.0 million.
The increase in BioRestorative Therapies' stock price could be attributed to positive investor sentiment or favorable company developments, suggesting a bullish short-term trend.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Cullinan Oncology's shares moved upwards by 20.89% to $20.01, with a market cap of $861.6 million.
The significant gain for Cullinan Oncology could indicate strong investor interest or positive news related to the company's operations or financial health, suggesting a bullish short-term outlook.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Dynatronics' stock rose 84.9% to $0.69, with a market cap of $3.3 million.
The substantial pre-market gain for Dynatronics suggests a positive short-term outlook, likely driven by investor optimism or positive news directly related to the company.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Inovio Pharmaceuticals' shares fell 24.3% to $8.32, with a market cap of $194.4 million.
The significant drop in Inovio Pharmaceuticals' stock price indicates negative sentiment or potentially adverse news affecting the company, leading to a pessimistic short-term outlook.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100